Antiphospholipid Antibodies in Neoplastic Patients
| Author | M R Mortazavizadeh | en |
| Author | R Sadeghmanesh | en |
| Issued Date | 2009-06-30 | en |
| Abstract | Background: Anti-phospholipid syndrome (APS) is an autoimmune systemic disease characterized by the persistent presence of anti-phospholipid antibodies (APA) and the occurrence of thrombotic events. Nowadays, the association between specific antibodies for anionic phospholipids with thrombotic events and other main clinical manifestations is well-recognized as "antiphospholipid syndrome". The present study was done to evaluate the frequency of antiphospholipid antibodies in neoplastic patients. | en |
| DOI | https://doi.org/ | en |
| Keyword | antiphospholipid antibody | en |
| Keyword | thrombotic events | en |
| Keyword | neoplastic patient | en |
| Publisher | Brieflands | en |
| Title | Antiphospholipid Antibodies in Neoplastic Patients | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- IJCM-80526.pdf
- Size:
- 115.82 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF